On ECHEMI
Home > Drugs > Shandong Qidu Pharmaceutical Co., Ltd.
Shandong Qidu Pharmaceutical Co., Ltd.
  • Founded in:

    1989-11-27
  • Country:

    China China
  • Address:

    No. 17, Hongda Road, Linzi District, Zibo City, Shandong Province
  • Tax NO.:

    91370305164323842H
  • Registered Funds:

    90 million yuan
  • Website:

  • Email:

Related Drugs
Piracetam Sodium Chloride Injection
The main ingredient of this product is piracetam. Its chemical name is: 2-oxido-1-pyrrolidinoacetamide. Excipients: sodium chloride, water for injection.
Name Description Content CAS NO. Registered Holders
Piracetam

This product is a brain metabolism improving drug, which is a cyclic derivative of г-aminobutyric acid. It has the effect of resisting brain function damage caused by physical and chemical factors. It can promote the generation of ATP in the brain, promote the synthesis of acetylcholine and enhance the conduction of nerve excitement, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improving effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability.

More

This product is a brain metabolism improving drug, which is a cyclic derivative of г-aminobutyric acid. It has the effect of resisting brain function damage caused by physical and chemical factors. It can promote the generation of ATP in the brain, promote the synthesis of acetylcholine and enhance the conduction of nerve excitement, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improving effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability.

7491-74-9 24
Roxithromycin Dispersible Tablets
The main component of this product is roxithromycin. 9-(O-[(2-methoxyethoxy)-methyl]oxime)erythromycin.
Name Description Content CAS NO. Registered Holders
Roxithromycin

This product is a semi-synthetic 14-membered macrolide antibiotic. Its antibacterial spectrum and antibacterial effect are basically similar to those of erythromycin. It is slightly less effective than erythromycin against Gram-positive bacteria, but stronger than erythromycin against Legionella pneumophila. Its antimicrobial effect against Chlamydia pneumoniae, Mycoplasma pneumoniae, and Ureaplasma urealyticum is similar to or slightly stronger than that of erythromycin. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the transfer of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.

More

This product is a semi-synthetic 14-membered macrolide antibiotic. Its antibacterial spectrum and antibacterial effect are basically similar to those of erythromycin. It is slightly less effective than erythromycin against Gram-positive bacteria, but stronger than erythromycin against Legionella pneumophila. Its antimicrobial effect against Chlamydia pneumoniae, Mycoplasma pneumoniae, and Ureaplasma urealyticum is similar to or slightly stronger than that of erythromycin. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the transfer of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.

80214-83-1 28
Matrine Glucose Injection
Matrine
Name Description Content CAS NO. Registered Holders
Matrine

Intraperitoneal injection of matrine into mice with cholestatic jaundice induced by 1-naphthyl isothiocyanate can reduce serum aspartate aminotransferase, alanine aminotransferase and serum conjugated bilirubin levels, and alleviate liver cell damage in model animals.

More

Intraperitoneal injection of matrine into mice with cholestatic jaundice induced by 1-naphthyl isothiocyanate can reduce serum aspartate aminotransferase, alanine aminotransferase and serum conjugated bilirubin levels, and alleviate liver cell damage in model animals.

519-02-8 8
Compound Amino Acid Injection (17AA-Ⅰ)
This product is a compound preparation, a sterile aqueous solution prepared from 17 kinds of amino acids and sorbitol. Its components (1000ml)
Name Description Content CAS NO. Registered Holders
Seventeen amino acids

Promote normal protein metabolism in the human body, correct negative nitrogen balance, supplement protein, and accelerate wound healing

More

Promote normal protein metabolism in the human body, correct negative nitrogen balance, supplement protein, and accelerate wound healing

0
Sorbitol

Promote normal protein metabolism in the human body, correct negative nitrogen balance, supplement protein, and accelerate wound healing

More

Promote normal protein metabolism in the human body, correct negative nitrogen balance, supplement protein, and accelerate wound healing

50-70-4 23
Metformin Glibenclamide Capsules (Ⅰ)
This product is a compound preparation, and its components are: each tablet contains 1.25 mg of glibenclamide and 250 mg of metformin hydrochloride.
Name Description Content CAS NO. Registered Holders
Glibenclamide

Mainly stimulates pancreatic β cells to secrete insulin to produce blood sugar lowering effect

More

Mainly stimulates pancreatic β cells to secrete insulin to produce blood sugar lowering effect

1.25mg 10238-21-8 28
1,1-DIMETHYLBIGUANIDE HYDROCHLORIDE

It can reduce the production of liver glycogen, reduce intestinal absorption of sugar, and improve insulin sensitivity by increasing peripheral sugar uptake and utilization

More

It can reduce the production of liver glycogen, reduce intestinal absorption of sugar, and improve insulin sensitivity by increasing peripheral sugar uptake and utilization

250mg 15537-72-1 55
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.